Compile Data Set for Download or QSAR
Report error Found 85 Enz. Inhib. hit(s) with all data for entry = 9634
TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM50318679(CHEMBL4162752 | US10889546, Example 44)
Affinity DataIC50: 13.7nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477226(US10889546, Example 35)
Affinity DataIC50: 70.4nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477229(US10889546, Example 38)
Affinity DataIC50: 79.2nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetProlyl hydroxylase EGLN3(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477219(US10889546, Example 28)
Affinity DataIC50: 99.2nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetProlyl hydroxylase EGLN3(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477232(US10889546, Example 41)
Affinity DataIC50: 101nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477238(US10889546, Example 46)
Affinity DataIC50: 102nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477225(US10889546, Example 34)
Affinity DataIC50: 110nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477219(US10889546, Example 28)
Affinity DataIC50: 125nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477224(US10889546, Example 33)
Affinity DataIC50: 170nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477237(US10889546, Example 45)
Affinity DataIC50: 175nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477240(US10889546, Example 48)
Affinity DataIC50: 178nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477230(US10889546, Example 39)
Affinity DataIC50: 186nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477239(US10889546, Example 47)
Affinity DataIC50: 187nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetProlyl hydroxylase EGLN3(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477198(US10889546, Example 8)
Affinity DataIC50: 210nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477246(US10889546, Example 54)
Affinity DataIC50: 211nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477197(US10889546, Example 7)
Affinity DataIC50: 215nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477247(US10889546, Example 55)
Affinity DataIC50: 221nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetProlyl hydroxylase EGLN3(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477231(US10889546, Example 40)
Affinity DataIC50: 221nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477211(US10889546, Example 20)
Affinity DataIC50: 234nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477257(US10889546, Example 65)
Affinity DataIC50: 290nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477205(US10889546, Example 14)
Affinity DataIC50: 298nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477244(US10889546, Example 52)
Affinity DataIC50: 310nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477210(US10889546, Example 19)
Affinity DataIC50: 310nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477242(US10889546, Example 50)
Affinity DataIC50: 311nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477256(US10889546, Example 64)
Affinity DataIC50: 326nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477227(US10889546, Example 36)
Affinity DataIC50: 378nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477228(US10889546, Example 37)
Affinity DataIC50: 390nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477252(US10889546, Example 60)
Affinity DataIC50: 399nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477258(US10889546, Example 66)
Affinity DataIC50: 400nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477234(US10889546, Example 43)
Affinity DataIC50: 402nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477251(US10889546, Example 59)
Affinity DataIC50: 405nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477243(US10889546, Example 51)
Affinity DataIC50: 442nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477254(US10889546, Example 62)
Affinity DataIC50: 450nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477208(US10889546, Example 17)
Affinity DataIC50: 464nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477232(US10889546, Example 41)
Affinity DataIC50: 489nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477212(US10889546, Example 21)
Affinity DataIC50: 510nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477233(US10889546, Example 42)
Affinity DataIC50: 515nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477245(US10889546, Example 53)
Affinity DataIC50: 520nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477253(US10889546, Example 61)
Affinity DataIC50: 527nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477249(US10889546, Example 57)
Affinity DataIC50: 540nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477231(US10889546, Example 40)
Affinity DataIC50: 544nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477198(US10889546, Example 8)
Affinity DataIC50: 550nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477207(US10889546, Example 16)
Affinity DataIC50: 564nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477206(US10889546, Example 15)
Affinity DataIC50: 567nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM50431015(CHEMBL2338329 | US9115085, Compound A Form A | US9...)
Affinity DataIC50: 599nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477250(US10889546, Example 58)
Affinity DataIC50: 606nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetProlyl hydroxylase EGLN3(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477201(US10889546, Example 11)
Affinity DataIC50: 645nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477241(US10889546, Example 49)
Affinity DataIC50: 653nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetEgl nine homolog 1(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477259(US10889546, Example 67)
Affinity DataIC50: 675nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

TargetProlyl hydroxylase EGLN3(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM477199(US10889546, Example 9)
Affinity DataIC50: 675nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 85 total ) | Next | Last >>
Jump to: